CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients

Sponsor
Universitaire Ziekenhuizen KU Leuven
Study ID
NCT07330323
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Verbal information only — BEHAVIORAL
    Verbal information only
  • Personalized Discharge Letter — BEHAVIORAL
    Personalized Discharge Letter: Tailored written information based on individual risk profile, skin type and consultation findings.
  • Personalized Discharge Letter + IntelliStudio — BEHAVIORAL
    Personalized Discharge Letter + IntelliStudio: Tailored written information plus digital visual support (e.g. annotated images, visual summaries).

Study Details

Current clinical practices often provide general verbal advice to low-risk patients, which may not sufficiently address individual concerns or offer actionable steps. Generic information on the internet can be overwhelming or unreliable, leading to confusion and unnecessary follow-up visits. This project introduces a tailored approach by combining evidence-based guidelines with personalized details about the patient's risk profile. The discharge letter bridges the gap between clinical expertise and patient understanding, offering clear, specific, and actionable advice that has been shown to improve health behaviors and outcomes in other contexts . The personalized discharge letters are generated using an AI agent trained on validated letters from the hospital's electronic health record system (KWS). Each letter is reviewed and approved by a physician before being provided to the patient, ensuring both accuracy and clinical relevance.

Key Dates

First listed
Jan 9, 2026
Start date
May 20, 2026
Status verified
Dec 2025
Primary completion
Jan 31, 2029
Completion
Jun 30, 2029

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Active Comparator: Group A: Standard of Care
    Verbal information only.
  • Experimental: Group B: Personalized Discharge Letter
    Tailored written information based on individual risk profile, skin type and consultation findings.
  • Experimental: Group C: Personalized Discharge Letter + Digital Visual Support (IntelliStudio)
    Tailored written information plus digital visual support (e.g. annotated images, visual summaries).

Primary Outcome Measure

Level of Reassurance Immediately Post-Consultation [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts

Find similar trials

Nationwide
Skin cancer trialsOncology trialsSkin cancer trialsDermatology trials

Related Studies